Answer
The median terminal half-life of talquetamab is 7.56 days at initial treatment and 12.2 days at steady state.
Sources for this answer
- TALVEY 2 mg/mL solution for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §5.2 Pharmacokinetic properties · Version 11Document updated
Sources checked